In the latest trading session,, 0.52 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.63. With the company’s most recent per share price at $0.50 changed hands at -$0.02 or -4.19% at last look, the market valuation stands at $2.40M. ZVSA’s current price is a discount, trading about -1160.0% off its 52-week high of $6.30. The share price had its 52-week low at $0.47, which suggests the last value was 6.0% up since then.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information

Instantly ZVSA was in red as seen in intraday trades today. With action -3.28%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -52.74%, with the 5-day performance at -3.28% in the red. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is -28.43% down.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 58.00%.

ZVSA Dividends

ZyVersa Therapeutics Inc is expected to release its next quarterly earnings report in June.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 18.08 shares estimated at $9228.0 under it, the former controlled 0.38% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.08% of the shares, roughly 3.63 shares worth around $1850.0.